RTOG 0848: A Phase III trial evaluating both Erlotinib and Chemoradiation as adjuvant treatment for patients with resected head of pancreas adenocarcinoma

Investigator: Lorraine Portelance

Institutional Protocol #: 20110584

National Clinical Trials Identifier: N/A

Funding Agency/Sponsor: RTOG

Division: Cancer Center

Therapeutic Area: Pancreatic, Liver, and Related Cancers

Phase: Phase III

Enrolling Sites: University of Miami Hospital & Clinics, UMD

Enrolling Since: 12/7/2011


Purpose/Abstract:

N/A

Eligibility Criteria:

Inclusion Criteria:

N/A

Exclusion Criteria:

N/A
Please note that this is written for scientific review, and if there are any questions or clarifications needed, please contact

Cancer Center Studies
1-866-574-5124

Back    

E-mail a Friend